Comerica Bank Sells 691 Shares of Maximus, Inc. (NYSE:MMS)

Comerica Bank lowered its holdings in Maximus, Inc. (NYSE:MMS) by 2.5% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 26,919 shares of the health services provider’s stock after selling 691 shares during the period. Comerica Bank’s holdings in Maximus were worth $2,009,000 at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Vanguard Group Inc. increased its position in shares of Maximus by 3.2% during the fourth quarter. Vanguard Group Inc. now owns 6,548,284 shares of the health services provider’s stock valued at $488,829,000 after buying an additional 205,564 shares during the period. Dimensional Fund Advisors LP grew its stake in Maximus by 14.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 1,406,592 shares of the health services provider’s stock valued at $105,001,000 after acquiring an additional 177,075 shares in the last quarter. Van Berkom & Associates Inc. increased its holdings in Maximus by 8.5% during the 4th quarter. Van Berkom & Associates Inc. now owns 1,256,418 shares of the health services provider’s stock worth $93,792,000 after acquiring an additional 98,264 shares during the period. Fuller & Thaler Asset Management Inc. lifted its stake in Maximus by 7.4% in the 4th quarter. Fuller & Thaler Asset Management Inc. now owns 1,234,933 shares of the health services provider’s stock worth $92,188,000 after purchasing an additional 84,835 shares in the last quarter. Finally, Charles Schwab Investment Management Inc. boosted its holdings in Maximus by 7.7% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 1,000,664 shares of the health services provider’s stock valued at $74,700,000 after purchasing an additional 71,598 shares during the period. 97.21% of the stock is currently owned by hedge funds and other institutional investors.

Maximus Stock Down 0.6 %

MMS stock opened at $75.31 on Friday. The company’s 50 day moving average is $68.07 and its 200 day moving average is $73.15. The stock has a market cap of $4.26 billion, a price-to-earnings ratio of 16.20 and a beta of 0.61. The company has a current ratio of 1.72, a quick ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a 1-year low of $63.77 and a 1-year high of $93.97.

Maximus (NYSE:MMS) last posted its quarterly earnings data on Thursday, May 8th. The health services provider reported $2.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.37 by $0.64. The company had revenue of $1.36 billion during the quarter, compared to the consensus estimate of $1.29 billion. Maximus had a net margin of 5.28% and a return on equity of 21.95%. The firm’s revenue was up 1.0% compared to the same quarter last year. During the same period in the previous year, the firm posted $1.57 EPS. Sell-side analysts predict that Maximus, Inc. will post 6.15 EPS for the current fiscal year.

Maximus Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date is Thursday, May 15th. This represents a $1.20 dividend on an annualized basis and a yield of 1.59%. Maximus’s payout ratio is 25.81%.

Insiders Place Their Bets

In other news, Director Jan Madsen sold 2,439 shares of the business’s stock in a transaction dated Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total value of $165,144.69. Following the completion of the sale, the director now owns 18,097 shares of the company’s stock, valued at approximately $1,225,347.87. The trade was a 11.88 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, insider Ilene R. Baylinson sold 14,500 shares of the firm’s stock in a transaction that occurred on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the transaction, the insider now owns 2,512 shares in the company, valued at approximately $171,167.68. The trade was a 85.23 % decrease in their ownership of the stock. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Wall Street Analysts Forecast Growth

Separately, StockNews.com upgraded Maximus from a “hold” rating to a “buy” rating in a research report on Wednesday.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.